Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01682941 · ClinicalTrials.gov registry record · NA
Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen
A NA study of Recurrent Prostate Cancer and Stage IV Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT01682941: Completed NA study of Recurrent Prostate Cancer and Stage IV Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01682941 is a NA study of Recurrent Prostate Cancer and Stage IV Prostate Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 32 participants, below the 137-participant average among 21 other Recurrent Prostate Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01682941, a NA study of Recurrent Prostate Cancer and Stage IV Prostate Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Eating a diet high in soy foods may lower the risk of some types of cancer. Isoflavones are compounds found in soy food that may prevent cancer. PURPOSE: This randomized phase II trial is studying how well soy isoflavones work in treating patients with recurrent prostate cancer or rising prostate-specific antigen
Primary Outcome
Quantification of absorption, serum concentrations over time, and excretion patterns of soy isoflavones and metabolites to define relationships between dietary intake, isoflavone metabolism and the biological outcomes
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Arm I Soy Bread
- DIETARY_SUPPLEMENT Arm II Soy-Almond Bread
Study Locations (1)
Ohio
- The Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-10 |
| Est. Completion | 2023-09-07 |
| Phase | NA |
What the finished NCT01682941 record still lists
NCT01682941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 137-participant average among 21 other Recurrent Prostate Cancer trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Recurrent Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Arm I Soy Bread is the first listed.
NCT01682941 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01682941 about?
NCT01682941 is a clinical study titled "Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen". RATIONALE: Eating a diet high in soy foods may lower the risk of some types of cancer. Isoflavones are compounds found in soy food that may prevent cancer. PURPOSE: This randomized phase II trial is studying how well soy isoflavones work in treating patients with recurrent prostate cancer or rising...
What is the current status of trial NCT01682941?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2009-10. Estimated completion is 2023-09-07.
What conditions does trial NCT01682941 study?
This clinical trial studies the following conditions: Recurrent Prostate Cancer, Stage IV Prostate Cancer.
What interventions are being tested in trial NCT01682941?
The interventions under investigation include: Arm I Soy Bread (DIETARY_SUPPLEMENT), Arm II Soy-Almond Bread (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01682941?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01682941 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01682941's enrollment target sits among peer trials
32 13th of 21 higher than 9 of 21 other Recurrent Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Recurrent Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
RECRUITING · Phase 2
-
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RECRUITING · Phase 2
-
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
RECRUITING · Phase 1
-
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
RECRUITING
-
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia